SC
TECH icon

Stance Capital’s Bio-Techne TECH Stock Holding History

Stance Capital’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.6K Buy
+299
New +$16.1K 0.01% 222

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Stance Capital's TECH Position: Q2 2026 in Review

Stance Capital opened a new position in Bio-Techne (TECH) in Q2 2026: 299 shares worth $20.6K. The stake represents 0.01% of the portfolio and ranks #222 among its holdings.

593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Stance Capital held 299 shares of Bio-Techne worth $20.6K as of Q2 2026.
  • Bio-Techne was a new Stance Capital position in Q2 2026.
  • Bio-Techne made up 0.01% of Stance Capital's portfolio in Q2 2026, its #222 holding.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Stance Capital's 13F filing for Q2 2026, filed 14 Aug 2026.